Group structure
4 companies in 1 country
Headquarters not stated2
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Medicines
Every medicine of every company in the group, current ones first.
10 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| BORTEZOMIB3.5mg/1.4ml (2.5mg/ml) ยท Solution | Bortezomib | United States | Marketed | 2024 |
| PEMETREXED100mg/10ml base (10mg/ml) | 1gm/100ml base (10mg/ml) | 500mg/50ml base (10mg/ml) ยท Solution | Pemetrexed | United States | Marketed | 2023 |
| Axyla | Teriflunomide | Saudi Arabia | Authorised | |
| Decanta | Decitabine | Saudi Arabia | Authorised | |
| Gemcitabine BOS | Gemcitabine | Saudi Arabia | Authorised | |
| Keroz | Fingolimod | Saudi Arabia | Authorised | |
| Lenvatinib TBM | Lenvatinib | Saudi Arabia | Authorised | |
| Retebin | Clofarabine | Saudi Arabia | Authorised | |
| Tredia | Dimethyl | Saudi Arabia | Authorised | |
| Valtroza | Bortezomib | Saudi Arabia | Authorised |



